Una herramienta para medir el impacto económico de la eliminación de la hepatitis B: un estudio de caso en Arabia Saudita
Summary Background No virologic cure exists for hepatitis B virus (HBV) infection, and existing therapies are designed to control viral replication. We aimed to estimate the national prevalence of HBsAg in 2017 and study the impact of an enhanced diagnosis rate and universal treatment administration on HBV-related outcomes in Saudi Arabia. Materials and methods A […]
Spanish 
English 
French 
Russian 
Arabic